- Home
- SAM vs HCM Comparison
SAM vs HCM Comparison
Compare SAM & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAM
- HCM
- Stock Information
- Founded
- SAM 1984
- HCM 2000
- Country
- SAM United States
- HCM Hong Kong
- Employees
- SAM N/A
- HCM N/A
- Industry
- SAM Beverages (Production/Distribution)
- HCM Biotechnology: Pharmaceutical Preparations
- Sector
- SAM Consumer Staples
- HCM Health Care
- Exchange
- SAM Nasdaq
- HCM Nasdaq
- Market Cap
- SAM 2.7B
- HCM 2.5B
- IPO Year
- SAM 1995
- HCM N/A
- Fundamental
- Price
- SAM $200.54
- HCM $15.85
- Analyst Decision
- SAM Hold
- HCM Hold
- Analyst Count
- SAM 10
- HCM 1
- Target Price
- SAM $276.33
- HCM $19.00
- AVG Volume (30 Days)
- SAM 272.5K
- HCM 104.1K
- Earning Date
- SAM 07-24-2025
- HCM 07-30-2025
- Dividend Yield
- SAM N/A
- HCM N/A
- EPS Growth
- SAM N/A
- HCM N/A
- EPS
- SAM 6.16
- HCM 0.04
- Revenue
- SAM $2,040,741,000.00
- HCM $630,201,000.00
- Revenue This Year
- SAM $2.79
- HCM $14.86
- Revenue Next Year
- SAM $2.61
- HCM $19.54
- P/E Ratio
- SAM $33.22
- HCM $68.21
- Revenue Growth
- SAM 0.79
- HCM N/A
- 52 Week Low
- SAM $185.34
- HCM $11.51
- 52 Week High
- SAM $329.55
- HCM $21.50
- Technical
- Relative Strength Index (RSI)
- SAM 42.47
- HCM 55.22
- Support Level
- SAM $186.72
- HCM $14.86
- Resistance Level
- SAM $199.03
- HCM $16.00
- Average True Range (ATR)
- SAM 6.53
- HCM 0.33
- MACD
- SAM 1.29
- HCM -0.08
- Stochastic Oscillator
- SAM 55.89
- HCM 44.40
About SAM Boston Beer Company Inc. (The)
Boston Beer is a top player in high-end malt beverages and adjacent categories in the us, with strong positions in craft beer, flavored malt beverages, hard cider, and hard seltzer. The bulk of volume and revenue is concentrated in four brands: Samuel Adams, Angry Orchard, Twisted Tea, and Truly. Beverages are produced using a hybrid model leveraging both in-house capacities and third-party breweries through contract arrangements. While the firm is required to use distributors to reach end markets, including retailers and on-premises operators, it also employs 500 internal sales representatives to educate the market about its products. The firm generates over 95% of sales in the us.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.